香港股市 已收市

濟民醫療 (603222.SS)

Shanghai - Shanghai 延遲價格。貨幣為 CNY。
加入追蹤清單
5.64-0.06 (-1.05%)
收市:03:00PM CST

濟民醫療

No. 888, Beiyuan Road
Huangyan District
Taizhou 318020
China
86 57 6840 66588
https://www.chimin.cn

版塊Healthcare
行業Medical Instruments & Supplies
全職員工1,947

描述

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells human medicines and medical devices in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products. In addition, the company provides in vitro diagnostics products, such as clinical chemical diagnostic, immunological diagnostic, blood testing, rapid diagnostic, and enzyme-linked immunological diagnostic reagents; laboratory instruments; and in vitro diagnostic medical products, as well as FOB fecal occult blood automatic immune monitoring and pylori Helicobacter detection kits. Further, it offers hemodialysis series products, including hemodialysis concentrate, hemodialysis tubing, and other products; and medical and health services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. and changed its name to Chimin Health Management Co., Ltd. in August 2018. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Taizhou, China.

公司管治

截至 無 止,濟民醫療 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。